Stem Cells – the 2013 event trilogy

Comparative study on effect of mesenchymal stem cells and endothelial progenitor cells on treatment of experimental CCL4-induced liver fibrosis

May 9, 2020May 9, 2020 Taylor No Comments

Background: We speculated impacts of BM-MSCs and UC-EPCs on reversal of hepatic injury induced by carbon tetrachloride (CCl4). Fifty adult rats were divided into five groups: control group, CCl4A group, CCl4B group, CCl4/BM-MSCs group and CCl4/UC-EPCs group. Blood samples were driven to measure concentration of albumin and ALT. Quantitative expression of HGF, TGF-β, MMP-2, and VEGF…

Comparative study on effect of mesenchymal stem cells and endothelial progenitor cells on treatment of experimental CCL4-induced liver fibrosis

Good Design Practices for an integrated containment and production system for Advanced Therapies

May 9, 2020May 9, 2020 Taylor No Comments

Advances in molecular biology and the potential of differentiating stemcells have opened up new situations in therapies that use progenitor or variously differentiated cells. Regardless of the selection of the system, designing a plant for producing superior therapies requires a transparent understanding of the ultimate goal (the product), bearing in mind all of the regulatory, atmosphere, course of,…

Good Design Practices for an integrated containment and production system for Advanced Therapies

Silencing of miR-330-5p stimulates osteogenesis in bone marrow mesenchymal stem cells and inhibits bone loss in osteoporosis by activating Bgn-mediated BMP/Smad pathway

May 9, 2020May 9, 2020 Taylor No Comments

To illustrate the position of micro ribonucleic acid (miR)-330-5p in regulating osteogenesis by way of biglycan (Bgn)-mediated bone morphogenetic protein (BMP)/Smad pathway. A mouse mannequin of osteoporosis (OP) was established by ovariectomy (OVX). BMD and miR-330-5p ranges in mice present process sham operation or OVX have been decided. BMD and BV/TV in OP mice with…

Silencing of miR-330-5p stimulates osteogenesis in bone marrow mesenchymal stem cells and inhibits bone loss in osteoporosis by activating Bgn-mediated BMP/Smad pathway

Newly synthesized peptide, Ara-27, exhibits significant improvement in cell-penetrating ability compared to conventional peptides

May 9, 2020January 24, 2022 Taylor No Comments

Cell-penetrating peptides (CPPs) are brief amino acid sequences recognized to act as a car for enhancing the intracellular translocating effectivity of additionalcellular molecules. Although many teams have tried to develop peptides with excessive cell-penetrating efficiencies, only a few have demonstrated environment friendly cellular uptake of CPPs at low concentrations. Here, we describe a newly synthesized peptide derived…

Newly synthesized peptide, Ara-27, exhibits significant improvement in cell-penetrating ability compared to conventional peptides

Stem cells and vascular dementia: from basic science to the clinic

April 10, 2020April 10, 2020 Taylor No Comments

Vascular dementia (VD) is the second most common cause of dementia following Alzheimer’s disease (AD). The major symptoms of VD including memory loss, language deficits and impairment of executive functions. Its specific etiology and pathogenesis remain unknown. Currently, treatment options of VD are still limited. The therapeutic strategies aim to control the vascular risk factors…

Stem Cells Research

Crosstalk between Dental Pulp Stem Cells and Endothelial Cells Augments Angiogenic Factor Expression

April 10, 2020April 10, 2020 Taylor No Comments

We aimed to investigate whether the mesenchymal stem cell-endothelial cell crosstalk enhances angiogenic factor expression via nuclear factor kappa B (NF-κB) dependent mechanisms.Human dermal microvascular endothelial cells (HDMECs) and stem cells from human exfoliated deciduous teeth (SHEDs) were co-cultured for 96 h, in the presence of NF-κB decoy oligodeoxynucleotides (ODN) or scramble (control). Vascular endothelial…

Stem Cells Research

Suppliers

April 6, 2020April 10, 2020 Taylor No Comments

Antibodies ACRO Biosystems CalBiotech Cedarlane Laboratories Ltd Elab Science Empire Genomics Jena Bioscience GMBH Panpath B.V. Synaptic Systems Gmbh ViroStat VLVbio Animal Alzet Osmotic Pumps EcoHealth Inc. Plastics One Inc Primetech Titermax USA, Inc iPrecio Mite Arrest Beads Chemicals; Organic/Inorganic/Radio-labelled Cell Culture inc 3D ELISA’s & Assays Equipment Immunogold Molecular Biology Plastic & Glassware Proteins…

Stem Cell Suppliers

April 6, 2020 Taylor No Comments

101BIO ABBIOTEC ABCLONAL ADIPOGEN ANACYTE APPLIEDSTEMCELL BETHYL BIOASSAY BIOCHEMICALS & REAGENTS BIOGENEX BIOTIUM BIOWORLD CELL & TISSUE CULTURE CHEMSCENE EASTCOAST BIO EUROMEX FINETEST GENWAYBIO HERCUVAN IMMUNOCHEMISTRY TECHNOLOGIES IMMUNOLOGY & PROTEOMICS INVENT BIOTECH KINGFISHER LAB EQUIPMENT & INSTRUMENT LC LABORATORIES MEDCHEM MOLECULAR BIOLOGY MOLECULAR DIMENSIONS MYBIOSOURCE ORIGENE PHYTOAB PHYTOTC POP-BIO IMAGING PROSPEC QEDBIOSCIENCES RANDOX LABORATORIES SANTA…

Past Stem Cell Events

April 4, 2020April 10, 2020 Taylor No Comments

Lausanne Genomics Days 10-11 February 2020 University of Lausanne, Génopode, Auditorium C 1015 Lausanne LS2 Meeting LS2 Annual Meeting 13-14 February 2020 University of Zürich – Campus Irchel 8057 Zürich

Uncategorized

Terapia komórkami macierzystymi

March 31, 2020April 3, 2020 Taylor No Comments

Terapia komórkami macierzystymi polega na wykorzystaniu komórek macierzystych do leczenia lub zapobiegania chorobie lub schorzeniu. Od 2016 r. Jedyną ustaloną terapią z wykorzystaniem komórek macierzystych jest hematopoetyczny przeszczep komórek macierzystych (HSCT). Zwykle ma to postać przeszczepu szpiku kostnego, ale komórki można również uzyskać z krwi pępowinowej. Trwają badania w celu opracowania różnych źródeł dla komórek…

Uncategorized